Chitosan Sponge: Advanced Hemostatic And Tissue Engineering Biomaterial With Multifunctional Properties

Molecular Composition And Structural Characteristics Of Chitosan Sponge

Chitosan sponge is fundamentally composed of chitosan, a linear polysaccharide consisting of β-(1→4)-linked D-glucosamine and N-acetyl-D-glucosamine units 1. The degree of deacetylation (DD) typically ranges from 70% to 95%, directly influencing the material's solubility, charge density, and biological activity 2. The cationic nature of chitosan, arising from protonated amino groups (–NH3+) at physiological pH, enables electrostatic interactions with negatively charged biological molecules such as red blood cells, proteins, and extracellular matrix components 13.

The three-dimensional porous architecture is achieved through freeze-drying (lyophilization) processes, where chitosan solutions or gels are frozen and subsequently subjected to vacuum sublimation 37. Key structural parameters include:

• Average pore size: 10–300 μm, optimized for cellular infiltration and nutrient diffusion 9
• Pore wall thickness: 5–270 μm, determining mechanical integrity and degradation kinetics 9
• Porosity: Typically 85–95%, enabling high fluid absorption capacity 712
• E-modulus (elastic modulus): 50–500 kPa, providing sufficient rigidity while maintaining flexibility 9

The interconnected porous network facilitates rapid capillary action, allowing chitosan sponges to absorb 10–30 times their dry weight in aqueous fluids 712. This high water absorption capacity is further enhanced by incorporating hydrophilic polymers such as polyethylene glycol (PEG, MW 1,500–8,000) or polypropylene glycol, which increase water absorption rate and magnification by disrupting crystalline regions and expanding the polymer network 12.

Chitosan sponges can be chemically modified to tailor functional properties. Carboxymethylation introduces anionic carboxyl groups, improving water solubility and enabling pH-responsive behavior 1318. Acylation with fatty acids (e.g., lauric, palmitic, or stearic acid) increases hydrophobicity and enhances cell adhesive protein binding, critical for tissue engineering scaffolds 10. Crosslinking strategies using glutaraldehyde, genipin, or sodium phytate stabilize the sponge structure, prevent premature dissolution in physiological fluids, and modulate degradation rates 714.

Composite Formulations And Functional Additives In Chitosan Sponge Systems

To address specific clinical requirements, chitosan sponges are frequently formulated as composites incorporating secondary polymers, inorganic fillers, or bioactive agents 146.

Chitosan-Hydroxyapatite And Chitosan-Montmorillonite Composites

Incorporation of hydroxyapatite (HA) or montmorillonite clay enhances mechanical strength, osteoconductivity, and hemostatic performance 1. Hydroxyapatite, a calcium phosphate ceramic (Ca10(PO4)6(OH)2), provides bioactive sites for bone cell attachment and mineralization, making chitosan-HA sponges suitable for bone regeneration applications 115. Montmorillonite, a layered aluminosilicate, increases surface area and adsorption capacity, accelerating blood coagulation through enhanced platelet activation 1.

Chitosan-Graphene Oxide Composite Sponges

Alkyl chitosan-graphene oxide (GO) composite sponges demonstrate superior hemostatic efficacy compared to pure chitosan 6. Graphene oxide, when adsorbed onto alkyl chitosan matrices at 3–28 wt%, significantly enhances blood absorption capacity and reduces hemostasis time 6. In vitro whole blood coagulation time is reduced to <58 seconds, while in vivo rabbit femoral artery hemorrhage models show hemostasis time <155 seconds with hemorrhage mass <5.4 g 6. The mechanism involves GO's high surface area (theoretical ~2,630 m²/g) and oxygen-containing functional groups (hydroxyl, epoxy, carboxyl) that promote platelet adhesion and activation of the intrinsic coagulation cascade 6.

Chitosan-MXene Antibacterial Composite Sponges

Ti3C2Tx MXene nanosheets incorporated into chitosan sponges via N-(2-hydroxyethyl)acrylamide monomer crosslinking provide dual hemostatic and antibacterial functionality 4. MXenes exhibit intrinsic antibacterial activity through membrane disruption and reactive oxygen species generation, while maintaining biocompatibility 4. The composite sponge demonstrates rapid hemostasis suitable for war wounds and trauma first aid, with good flexibility and mechanical strength for diverse wound geometries 4.

Chitosan-Alginate Blend Sponges

Alginate (alginic acid) and chitosan form polyelectrolyte complexes through ionic interactions between carboxyl groups (–COO⁻) of alginate and amino groups (–NH3+) of chitosan 7. The resulting blend sponges combine chitosan's hemostatic properties with alginate's high water absorption and gel-forming capacity 7. Preparation involves mixing micron or nano-scale insoluble calcium salt powder (e.g., CaCO3, CaSO4) with sodium alginate solution, followed by slow addition of chitosan acid solution to form alginate-chitosan gel, which is then homogenized, defoamed, and freeze-dried 7. The sponges exhibit good softness, can be folded arbitrarily, absorb water rapidly while maintaining structural integrity, and are non-toxic with excellent biocompatibility 7. They are particularly suitable for managing severe exudates or deep wound cavities 7.

Chitosan-Collagen Mixed Sponges

Collagen incorporation enhances cell adhesion, proliferation, and tissue integration 89. The optimal weight ratio of collagen to chitosan ranges from 1:8 to 1:2, balancing mechanical properties with biological activity 9. Neutralized chitosan-collagen sponges (pH ~7.0) demonstrate improved biocompatibility and reduced inflammatory responses compared to acidic chitosan formulations 9. These sponges can be further enriched with growth factors (basic fibroblast growth factor [bFGF], epidermal growth factor [EGF], transforming growth factor-β [TGF-β]) or extracellular matrix proteins (fibronectin) to accelerate wound healing and tissue regeneration 915.

Chitosan-Polyvinyl Alcohol (PVA) Composite Sponges

Chitosan-PVA blends offer enhanced mechanical strength and reduced linting compared to pure chitosan sponges 14. Crosslinking with non-formaldehyde agents (e.g., citric acid, genipin) eliminates cytotoxicity concerns associated with residual formaldehyde 14. The composite sponges maintain high water absorption capacity while providing superior tensile strength, making them suitable for high-exudate wounds 14.

Manufacturing Processes And Process Optimization For Chitosan Sponge Production

The production of chitosan sponges involves multiple critical steps that determine final product quality, reproducibility, and scalability 3717.

Chitosan Solution Preparation

Chitosan is dissolved in dilute organic acids (typically 0.5–3% acetic acid, lactic acid, or formic acid) to achieve concentrations of 0.5–4% w/v 3717. The choice of acid and concentration affects solution viscosity, pH, and subsequent gelation behavior 3. For composite formulations, secondary polymers (collagen, alginate, PVA) are prepared as separate solutions and blended under controlled stirring to ensure homogeneity 78.

Gelation And Crosslinking

Chitosan solutions can be converted to gels through:

• Physical gelation: pH adjustment using alkaline solutions (NaOH, NH4OH) to neutralize protonated amino groups, inducing polymer chain aggregation 9
• Ionic crosslinking: Addition of polyanions (sodium tripolyphosphate, sodium phytate) or multivalent cations (Ca²⁺, Fe³⁺) to form ionic bridges 57
• Chemical crosslinking: Reaction with bifunctional reagents (glutaraldehyde, genipin, citric acid) to form covalent bonds between polymer chains 14

Crosslinking density must be optimized to balance mechanical strength, degradation rate, and biocompatibility 14. Over-crosslinking reduces water absorption and cellular infiltration, while under-crosslinking leads to premature dissolution 7.

Freeze-Drying (Lyophilization) Process

Freeze-drying is the most widely employed method for creating porous chitosan sponges 3717. The process comprises:

1. Freezing: Chitosan gel is frozen at –20°C to –80°C, with freezing rate controlling ice crystal size and pore morphology 316. Slow freezing produces larger ice crystals and correspondingly larger pores, while rapid freezing generates smaller, more uniform pores 16.

2. Primary drying (sublimation): Under vacuum (0.01–0.1 mbar), ice crystals sublimate directly from solid to vapor phase, leaving behind a porous scaffold 317. Temperature is maintained below the eutectic point or glass transition temperature to prevent collapse 17.

3. Secondary drying (desorption): Residual bound water is removed by gradually increasing temperature (20–40°C) under continued vacuum 17.

Traditional freeze-drying cycles require 42–48 hours 17. Recent process optimization has reduced this to 12–15 hours through:

• Annealing: Holding frozen samples at –10°C to –20°C for 1–2 hours to promote ice crystal growth and uniformity, facilitating faster sublimation 17
• Optimized shelf temperature ramping: Controlled temperature increases during primary drying to maximize sublimation rate without inducing collapse 17
• Reduced sample thickness: Limiting gel thickness to 5–15 mm to decrease diffusion path length for water vapor 16

Post-lyophilization, sponges may undergo heat treatment (60–80°C for 15–30 minutes) to enhance crosslinking and mechanical stability 17.

Washing And Neutralization

For sponges prepared with acidic chitosan solutions, thorough washing with deionized water or buffer solutions is essential to remove residual acid and achieve neutral pH 39. Neutralization can also be performed by immersing sponges in alkaline solutions (0.1–1 M NaOH) followed by extensive rinsing 9. Incomplete neutralization may cause tissue irritation upon implantation 9.

Sterilization

Chitosan sponges are sterilized using gamma irradiation (⁶⁰Co source, 4–25 kGy), ethylene oxide gas, or electron beam irradiation 17. Gamma irradiation is preferred for its deep penetration and effectiveness without heat exposure, though doses >25 kGy may cause polymer chain scission and reduced molecular weight 17. Sponges are typically packaged in nitrogen-purged pouches prior to sterilization to minimize oxidative degradation 17.

Hemostatic Mechanisms And Performance Characteristics Of Chitosan Sponge

Chitosan sponges exhibit multifaceted hemostatic mechanisms that enable rapid blood coagulation and hemorrhage control 1246.

Electrostatic Interaction And Red Blood Cell Aggregation

The positive charge of chitosan (pKa ~6.5) at physiological pH attracts negatively charged red blood cells (RBCs), which possess a surface zeta potential of approximately –15 to –20 mV due to sialic acid residues on membrane glycoproteins 1. This electrostatic attraction promotes RBC adhesion to the sponge surface and subsequent aggregation, forming a physical barrier that occludes bleeding sites 12.

Platelet Activation And Coagulation Cascade Initiation

Chitosan activates platelets through multiple pathways:

• Contact activation: Chitosan's cationic surface activates Factor XII (Hageman factor) of the intrinsic coagulation pathway, initiating the cascade leading to thrombin generation and fibrin formation 26
• Platelet adhesion: Chitosan binds to platelet membrane receptors (e.g., GPIb, GPIIb/IIIa), triggering shape change, degranulation, and release of procoagulant factors (ADP, thromboxane A2, von Willebrand factor) 6
• Thrombin generation enhancement: Chitosan provides a negatively charged surface for assembly of coagulation factor complexes (tenase, prothrombinase), accelerating thrombin production 2

Fluid Absorption And Concentration Of Coagulation Factors

Chitosan sponges rapidly absorb blood and wound exudate (10–30× dry weight), concentrating platelets, coagulation factors, and fibrinogen at the wound site 712. This local concentration effect accelerates clot formation and stabilization 24.

Quantitative Hemostatic Performance

Performance metrics from patent literature include:

• In vitro whole blood coagulation time: 45–58 seconds for chitosan-GO composites 6, compared to 120–180 seconds for gauze controls
• In vivo hemostasis time (rabbit femoral artery model): 95–155 seconds for chitosan composites 6, versus 240–300 seconds for standard hemostatic agents
• Hemorrhage mass reduction: 3.8–5.4 g for chitosan sponges 6, compared to 12–18 g for conventional dressings
• Blood absorption capacity: 15–28 g/g for optimized chitosan sponges 712

Composite formulations with graphene oxide, MXene, or hydroxyapatite demonstrate 30–50% improvement in hemostatic efficacy compared to pure chitosan sponges 46.

Antimicrobial Properties And Infection Control Mechanisms

Chitosan sponges possess intrinsic antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria, and fungi 14.

Mechanisms Of Antimicrobial Action

1. Membrane disruption: Cationic chitosan interacts with negatively charged bacterial cell membranes (lipopolysaccharides in Gram-negative bacteria, teichoic acids in Gram-positive bacteria), causing membrane permeabilization, leakage of intracellular contents, and cell death 14

2. DNA binding and transcription inhibition: Low molecular weight chitosan (<10 kDa) can penetrate bacterial cells and bind to DNA, interfering with transcription and protein synthesis 4

3. Metal ion chelation: Chitosan chelates essential metal ions (Fe²⁺, Zn²⁺, Cu²⁺) required for bacterial metabolism and enzyme function 4

4. Reactive oxygen species (ROS) generation: MXene-containing chitosan composites generate ROS that oxidize bacterial membrane lipids and proteins 4

Antimicrobial Efficacy Data

Chitosan-MXene composite sponges demonstrate:

• Minimum inhibitory concentration (MIC): 64–128 μg/mL against Staphylococcus aureus and Escherichia coli 4
• Zone of inhibition: 18–24 mm diameter in disk diffusion assays 4
• Bacterial reduction: >99.9% (3-log reduction) within 24 hours of contact 4

The antimicrobial activity is enhanced by:

• Increasing degree of deacetylation (higher cationic charge density) 1
• Reducing chitosan molecular weight (improved cell penetration) 4
• Incorporating antimicrobial agents (silver nanoparticles, antibiotics, essential oils) 4

Biocompatibility,